Oncolytics Biotech Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 27, 2023 / 12:35PM GMT
Carvey Leung - Cantor Fitzgerald - Analyst

Good morning, everyone. My name is Carvey. I'm a research associate here in Cantor. Thank you for joining us, Matt, for our fireside chat.

To start, can you tell us about your role at the company?

Matt Coffey - Oncolytics Biotech Inc. - President and CEO

Yeah. I'm Matt Coffey. I'm the President and CEO. And I was fortunate enough to actually be involved in the discovery team that was involved in the initial discovery that this could potentially act as a cancer therapeutic.

Questions and Answers:

Carvey Leung - Cantor Fitzgerald - Analyst

Awesome. Well, thank you for the introduction. What's your company's strategic vision? And where do you see the company, say, in three to five years?

Matt Coffey - Oncolytics Biotech Inc. - President and CEO

We're actually at a very interesting time right now. We have been selected by a non-profit called PanCAN, which is running a Phase 3 for us, and it's an ongoing development
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot